Evidence map›Paper›PMID 31590424›Full record

ArticleInternational journal of environmental research and public health2019

Co-producing Progression Criteria for Feasibility Studies: A Partnership between Patient Contributors, Clinicians and Researchers.

Hannah M L Young, Samantha Goodliffe, Meeta Madhani, Kay Phelps, Emma Regen, Anthony Locke, James O Burton, Sally J Singh, Alice C Smith, Simon Conroy

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. BMJ open · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hannah M L YoungDepartment of Respiratory Sciences, University of Leicester, Leicester LE1 7RH, UK. hannah.young@uhl-tr.nhs.uk.
Samantha GoodliffeDepartment of Respiratory Sciences, University of Leicester, Leicester LE1 7RH, UK. samanthagoodliffe@yahoo.co.uk.ORCID 0000-0002-6208-5148
Meeta MadhaniLeicester Kidney Lifestyle Haemodialysis Patient Involvement Group, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester LE1 5WW, UK. MM4870@yahoo.co.uk.
Kay PhelpsDepartment of Health Sciences, University of Leicester, Leicester LE1 7RH, UK. kp14@leicester.ac.uk.ORCID 0000-0003-4735-4669
Emma RegenDepartment of Health Sciences, University of Leicester, Leicester LE1 7RH, UK. elr14@leicester.ac.uk.ORCID 0000-0002-8786-2783
Anthony LockeAging Related Research Patient and Public Involvement Group, University of Leicester, Leicester LE1 7RH, UK. anthonylocke@btopenworld.com.
James O BurtonNational Centre for Sport and Exercise Medicine, Loughborough University, Loughborough LE11 3TU, UK. jb343@le.ac.uk.
Sally J SinghDepartment of Respiratory Sciences, University of Leicester, Leicester LE1 7RH, UK. sally.singh@uhl-tr.nhs.uk.
Alice C SmithAging Related Research Patient and Public Involvement Group, University of Leicester, Leicester LE1 7RH, UK.
Simon ConroyDepartment of Health Sciences, University of Leicester, Leicester LE1 7RH, UK. spc3@le.ac.uk.

Funding

Department of Health CS-2013-13-014Department of Health DRF-2016-09-015
6 · The paper itself

Abstract

There is a lack of guidance for developing progression criteria (PC) within feasibility studies. We describe a process for co-producing PC for an ongoing feasibility study. Patient contributors, clinicians and researchers participated in discussions facilitated using the modified Nominal Group Technique (NGT). Stage one involved individual discussion groups used to develop and rank PC for aspects of the trial key to feasibility. A second stage involving representatives from each of the individual groups then discussed and ranked these PC. The highest ranking PC became the criteria used. At each stage all members were provided with a brief education session to aid understanding and decision-making. Fifty members (15 (29%) patients, 13 (25%) researchers and 24 (46%) clinicians) were involved in eight initial groups, and eight (two (25%) patients, five (62%) clinicians, one (13%) researcher) in one final group. PC relating to eligibility, recruitment, intervention and outcome acceptability and loss to follow-up were co-produced. Groups highlighted numerous means of adapting intervention and trial procedures should 'change' criteria be met. Modified NGT enabled the equal inclusion of patients, clinician and researcher in the co-production of PC. The structure and processes provided a transparent mechanism for setting PC that could be replicated in other feasibility studies.

Indexed as

Feasibility StudiesPatientsResearch DesignDecision MakingGroup ProcessesHealth PersonnelHumansResearch Personnelconsensusco-productionfeasibilitynominal group techniquepatient involvementprogression criteria

Identifiers

PMID31590424
PMCPMC6801439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.